Royce & Associates LP grew its position in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) by 35.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 99,715 shares of the company’s stock after buying an additional 26,045 shares during the quarter. Royce & Associates LP’s holdings in Enfusion were worth $946,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Scalar Gauge Management LLC grew its holdings in Enfusion by 21.8% during the second quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company’s stock worth $5,227,000 after acquiring an additional 110,000 shares during the period. Renaissance Technologies LLC grew its stake in shares of Enfusion by 167.6% during the 2nd quarter. Renaissance Technologies LLC now owns 97,100 shares of the company’s stock worth $827,000 after purchasing an additional 60,811 shares during the period. Squarepoint Ops LLC acquired a new position in shares of Enfusion during the 2nd quarter worth $683,000. SG Americas Securities LLC purchased a new position in shares of Enfusion in the 3rd quarter valued at about $892,000. Finally, Dimensional Fund Advisors LP boosted its holdings in Enfusion by 57.5% during the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company’s stock worth $4,466,000 after buying an additional 191,436 shares in the last quarter. Hedge funds and other institutional investors own 81.05% of the company’s stock.
Enfusion Trading Up 2.6 %
Shares of ENFN opened at $9.89 on Thursday. Enfusion, Inc. has a twelve month low of $7.52 and a twelve month high of $10.45. The firm has a market capitalization of $1.27 billion, a P/E ratio of 240.75, a PEG ratio of 3.66 and a beta of 0.93. The firm’s 50-day moving average is $9.06 and its two-hundred day moving average is $8.85.
Enfusion Profile
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
Featured Stories
- Five stocks we like better than Enfusion
- How to Most Effectively Use the MarketBeat Earnings Screener
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Williams-Sonoma Stock: Buy It and Never Let It Go
- High Flyers: 3 Natural Gas Stocks for March 2022
- 5 Dividend ETFs to Buy and Hold Forever
Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFN – Free Report).
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.